BAC
Bank of America Corporation
BAC has the edge over CSWC overall, supported by stronger valuation and stronger fundamentals.
CSWC
Capital Southwest Corporation
CSWC trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CSWC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CSWC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CSWC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CSWC in the historical PE scenario, which offers more potential upside but is not a forecast.
CSWC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9x | $15.26 | -35% |
| Forward | 9.8x | $23.50 | — |
| Fair | 11x | $18.28 | -22% |
| Current | 14x | $23.50 | — |
| Expensive | 15x | $25.07 | +6.7% |
Historical ranges are pointers, not guarantees.
CSWC's PE is in its expensive range at 14x. On analysts' estimates for next year's earnings, today's price would be 9.8x, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over CSWC on the outlook, with more favorable earnings and profitability expectations.
CSWC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect CSWC's revenue to grow, but its profitability to weaken.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CSWC on earnings, with more consistent year-over-year improvement.
CSWC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.39 | +41% |
| Q3 2026 | $1.70 | +5.6% |
| Q2 2026 | $1.81 | -1.1% |
| Q1 2026 | $1.90 | -4% |
| Q4 2025 | $1.81 | -21% |
| Q3 2025 | $1.61 | -39% |
| Q2 2025 | $1.83 | -32% |
| Q1 2025 | $1.98 | -27% |
| Q4 2024 | $2.30 | -14% |
CSWC's earnings per share have fallen from their peak: $1.70 over the past year, against $2.94 in mid-2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 44% for CSWC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
CSWC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $13.9M | -44% |
| Q1 2022 | $30M | +49% |
| Q4 2021 | $23.7M | -12% |
| Q3 2021 | $24.1M | -6.4% |
| Q2 2021 | $25.1M | +42% |
| Q4 2020 | $26.9M | +374% |
CSWC's revenue is shrinking: $14M last quarter, down 44% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 29% | -35 points |
| Q1 2022 | 70% | +13 points |
| Q4 2021 | 56% | -9.4 points |
| Q3 2021 | -13% | -79 points |
| Q2 2021 | 64% | +8.6 points |
| Q1 2021 | 56% | N/A |
| Q4 2020 | 65% | +108 points |
| Q3 2020 | 66% | N/A |
CSWC's operating margin was 29% last quarter, down 35 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over CSWC on cash generation, producing positive trailing cash flow while its opponent burns cash.
CSWC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$193.1M | -$121.8M |
| Q2 2026 | -$80.9M | -366% |
| Q1 2026 | -$59.2M | -$64K |
| Q4 2025 | -$93.6M | +$72.9M |
| Q3 2025 | -$71.3M | -$47M |
| Q2 2025 | $30.4M | -2.4% |
| Q1 2025 | -$59.1M | +$43M |
| Q4 2024 | -$166.6M | -1025% |
CSWC's free cash flow was −$427M over the past year, against −$267M the year before. Free cash flow isn't a meaningful measure for financial services companies like CSWC.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CSWC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CSWC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +2.5M shares |
| 1 year | +13% | +8.2M shares |
| 3 years | +84% | +33.3M shares |
| 5 years | +224% | +50.5M shares |
| Available history | +304% | +54.9M shares |
CSWC has 73M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $236,000 |
| Q3 2020 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CSWC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 15.0x | High |
| Q1 2022 | 10.5x | High |
| Q4 2021 | 12.3x | High |
| Q3 2021 | 10.1x | High |
| Q2 2021 | 6.8x | High |
| Q1 2021 | 6.1x | High |
| Q4 2020 | 15.6x | High |
| Q3 2020 | 215.5x | High |
CSWC's net debt is about 15 years of its operating earnings (EBITDA), up from 6.8 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CSWC.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CSWC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 33.9 | Neutral |
CSWC's weekly RSI is 50 (neutral) and its Stochastic is 34 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CSWC on valuation relative to its sector.
CSWC PE vs Financial Services Sector
| Metric | CSWC | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6.1% above |
| PE % | 76 | 63 | 13 pts above |
CSWC is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CSWC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.2 | 1.3% above |
| 20 week MA | $23.9 | 1.5% below |
| 50 week MA | $23.2 | 1.2% above |
| 100 week MA | $22.5 | 4.5% above |
| 200 week MA | $22.5 | 4.3% above |
CSWC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CSWC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $16.6 | -21% |
| 2021 | $16.6 | $25.3 | +53% |
| 2022 | $25.3 | $17.3 | -32% |
| 2023 | $17.3 | $23.7 | +37% |
| 2024 | $23.7 | $21.6 | -8.9% |
| 2025 | $21.6 | $21.9 | +1.6% |
| 2026 YTD | $21.9 | $23.5 | +7.2% |
CSWC has the edge over BAC on returns for 2026, with the stronger performance.